Open Ablation of the Left Ventricle During Implantation of a Left Ventricular Assist Device

Yuriy Hrytsyna1, Jin-Hong Gerds-Li2, Roland Heck1

  • 1Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.

Insights

This study details successful treatment of persistent ventricular tachycardia during left ventricular assist device (LVAD) implantation. Radiofrequency ablation combined with LVAD implantation effectively stabilized the patient's cardiac rhythm.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Electrophysiology

Background:

  • Persistent ventricular tachycardia (VT) poses a significant challenge in patients with ischemic cardiomyopathy.
  • Recurrent VT can lead to cardiac decompensation, necessitating advanced interventions.
  • Left ventricular assist device (LVAD) implantation is a critical option for end-stage heart failure.

Observation:

  • A 66-year-old patient with ischemic cardiomyopathy presented with recurrent VT causing cardiac decompensation.
  • The patient underwent implantation of a HeartMate 3 LVAD.
  • During the procedure, radiofrequency ablation was performed using an AtriCure Isolator Synergy OLL2 clamp.

Findings:

  • Four sets of transmural radiofrequency lesions were created in the left ventricle.
  • Transmurality of all lesions was confirmed.
  • The ablation lesions were connected with an epicardial ablation line.

Implications:

  • This combined approach of radiofrequency ablation and LVAD implantation offers a potential solution for managing refractory VT in patients with severe cardiomyopathy.
  • Successful rhythm stabilization post-procedure suggests the efficacy of this integrated therapeutic strategy.
  • The patient's uneventful discharge with a stable rhythm highlights the safety and effectiveness of this intervention.